Sophie A. Kurk

Zeist, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial.

Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 11, 2025

Real-time data in cancer registries: Validation of an automated data extraction system.

Real-time data in cancer registries: Validation of an automated data extraction system.

Journal: iScience

Published: September 10, 2024

Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation study.

Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation study.

Journal: Clinical nutrition ESPEN

Published: June 18, 2024

Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.

Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.

Journal: Digestive surgery

Published: October 20, 2020

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics.

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics.

Journal: Cancer medicine

Published: October 06, 2020

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.

Journal: Cancer medicine

Published: March 05, 2019

Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer.

Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer.

Journal: JNCI cancer spectrum

Published: January 10, 2019

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.

Journal: The American journal of clinical nutrition

Published: December 21, 2018

The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

Journal: Journal of geriatric oncology

Published: December 20, 2018

The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer.

The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer.

Journal: Journal of cachexia, sarcopenia and muscle

Published: October 18, 2018

Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.

Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.

Journal: Journal of cachexia, sarcopenia and muscle

Published: October 17, 2018

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.

Journal: Journal of cachexia, sarcopenia and muscle

Published: June 15, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026